Therapeutic agents for use in the prophylaxis and/or treatment of hyperkinetic movement disorders

The present invention relates to the use of (RS)-[2-(3,4-dimethoxyphenyl)ethyl][2-hydroxy-3-(3-methylphenoxy)propyl]amine having the formula (IA), or a pharmaceutically acceptable salt thereof for the formulation of a pharmaceutical composition,useful for the prophylaxis and/or the treatment of hype...

Full description

Saved in:
Bibliographic Details
Main Authors Insa Boronat, Raúl, Reig Bolaño, Núria, Gavaldà Batalla, Núria
Format Patent
LanguageEnglish
Published 26.03.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to the use of (RS)-[2-(3,4-dimethoxyphenyl)ethyl][2-hydroxy-3-(3-methylphenoxy)propyl]amine having the formula (IA), or a pharmaceutically acceptable salt thereof for the formulation of a pharmaceutical composition,useful for the prophylaxis and/or the treatment of hyperkinetic movement disorders associated with Huntington's disease, Wilson's disease, Tourette syndrome, restless leg syndrome, and tardive dyskinesia.
Bibliography:Application Number: NZ20140715951